IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

In 35 patients with hypertrophic cardiomyopathy, the effects of ivabradine (15 mg/d) and atenolol (50 mg/d) on physical stress tolerability (veloergometry test results) were investigated. Ivabradine and atenolol therapy was associated with increased test time: +1,5 minutes (p<0,01) and +2,4 m...

Full description

Bibliographic Details
Main Authors: P. Kh. Dzhanashiya, I. V. Markelova, N. S. Krylova, E. V. Avdeeva, V. A. Nazarenko, S. A. Nikolenko
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2010-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1421
id doaj-de75f26e6aa34e498f1c60bc412344b7
record_format Article
spelling doaj-de75f26e6aa34e498f1c60bc412344b72021-07-28T14:02:13Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202010-02-010159641209IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHYP. Kh. Dzhanashiya0I. V. Markelova1N. S. Krylova2E. V. Avdeeva3V. A. Nazarenko4S. A. Nikolenko5Кафедра общей терапии факультета усовершенствования врачей РГМУ Росздрава, МоскваКафедра общей терапии факультета усовершенствования врачей РГМУ Росздрава, МоскваКафедра общей терапии факультета усовершенствования врачей РГМУ Росздрава, МоскваКафедра общей терапии факультета усовершенствования врачей РГМУ Росздрава, МоскваКафедра общей терапии факультета усовершенствования врачей РГМУ Росздрава, МоскваКафедра общей терапии факультета усовершенствования врачей РГМУ Росздрава, МоскваIn 35 patients with hypertrophic cardiomyopathy, the effects of ivabradine (15 mg/d) and atenolol (50 mg/d) on physical stress tolerability (veloergometry test results) were investigated. Ivabradine and atenolol therapy was associated with increased test time: +1,5 minutes (p<0,01) and +2,4 minutes (p<0,01), respectively. Both medications prevented angina attacks and paradoxical blood pressure drop during the physical stress test.https://russjcardiol.elpub.ru/jour/article/view/1421hypertrophic cardiomyopathyivabradineatenolol
collection DOAJ
language Russian
format Article
sources DOAJ
author P. Kh. Dzhanashiya
I. V. Markelova
N. S. Krylova
E. V. Avdeeva
V. A. Nazarenko
S. A. Nikolenko
spellingShingle P. Kh. Dzhanashiya
I. V. Markelova
N. S. Krylova
E. V. Avdeeva
V. A. Nazarenko
S. A. Nikolenko
IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
Российский кардиологический журнал
hypertrophic cardiomyopathy
ivabradine
atenolol
author_facet P. Kh. Dzhanashiya
I. V. Markelova
N. S. Krylova
E. V. Avdeeva
V. A. Nazarenko
S. A. Nikolenko
author_sort P. Kh. Dzhanashiya
title IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
title_short IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
title_full IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
title_fullStr IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
title_full_unstemmed IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
title_sort ivabradin and atenolol effectiveness comparison in patients with hypertrophic cardiomyopathy
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2010-02-01
description In 35 patients with hypertrophic cardiomyopathy, the effects of ivabradine (15 mg/d) and atenolol (50 mg/d) on physical stress tolerability (veloergometry test results) were investigated. Ivabradine and atenolol therapy was associated with increased test time: +1,5 minutes (p<0,01) and +2,4 minutes (p<0,01), respectively. Both medications prevented angina attacks and paradoxical blood pressure drop during the physical stress test.
topic hypertrophic cardiomyopathy
ivabradine
atenolol
url https://russjcardiol.elpub.ru/jour/article/view/1421
work_keys_str_mv AT pkhdzhanashiya ivabradinandatenololeffectivenesscomparisoninpatientswithhypertrophiccardiomyopathy
AT ivmarkelova ivabradinandatenololeffectivenesscomparisoninpatientswithhypertrophiccardiomyopathy
AT nskrylova ivabradinandatenololeffectivenesscomparisoninpatientswithhypertrophiccardiomyopathy
AT evavdeeva ivabradinandatenololeffectivenesscomparisoninpatientswithhypertrophiccardiomyopathy
AT vanazarenko ivabradinandatenololeffectivenesscomparisoninpatientswithhypertrophiccardiomyopathy
AT sanikolenko ivabradinandatenololeffectivenesscomparisoninpatientswithhypertrophiccardiomyopathy
_version_ 1721269601822572544